The study aims to investigate the alexithymia construct in patients with a recent or longtime diagnosis of cancer as well as in healthy people, and whether alexithymia and fatigue are linked in the mentioned groups.
Methods
A first group, diagnosed less than 3 months previously (n = 63), and a second group whose cancer diagnosis dated back more than 30 months (n = 53), matched for sex, age, educational level and cancer site were assessed. Matched healthy controls (n = 50) were also evaluated. Alexithymia was assessed with the Toronto Alexithymia Scale-20, while fatigue was assessed with the Brief Fatigue Inventory.
Results
Alexithymia scores were higher in the recently diagnosed group than in the group with a longtime cancer diagnosis (t = 2.18, P <0.05). Both groups had higher scores than controls (t = 4.3, P <0.001; t = 2.01, P <0.05). Alexithymic subjects were 45.6% in the recently diagnosed and 21.4% in the longtime diagnosed group (χ2 = 6.3, P <0.05) and 18% in controls. Fatigue was more severe in patients with a longtime diagnosis compared with recently diagnosed patients (t = 7.079, P = 0.000). A weak but significant association between fatigue and alexithymia was found in recently diagnosed patients (r = 0.27.2; P <0.05).
Conclusions
Our study confirms that alexithymia scores are higher in cancer patients than in controls. The study suggests that alexithymia could be considered a dynamic reaction to illness in recently diagnosed patients, declining during subsequent phases. High fatigue rates in patients with a longtime diagnosis of cancer underline the role of the long course of illness in the perception of fatigue. The association between fatigue and alexithymia was weak in the recently diagnosed group and not significant in patients with a longtime diagnosis, in whom fatigue was an important complaint.
SifneosP.E.: The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom, 22: 255–262, 1973.
2.
TaylorG.J., BagbyR.M.: New trends in alexithymia research. Psychoter Psychosom, 73: 68–77, 2004.
3.
de VenteW., KamphuisJ.H., EmmelkampP.M.: Alexithymia, risk factor or consequence of work-related stress?Psychoter Psychosom, 75: 304–311, 2006.
4.
SifneosP.E.: Alexithymia: past and present. Am J Psychiatry, 153: 137–142, 1996.
5.
TaylorG.J., BagbyR.M., ParkerJ.D.A.: Disorders of affect regulation: alexithymia in medical and psychiatric illness.Cambridge University Press, Cambridge, 1997.
6.
PorcelliP., LeociC., GuerraV., TaylorG.J., BagbyR.M.: A longitudinal study of alexithymia and psychological stress in infiammatory bowel disease. J Psychosom Res, 41: 569–573, 1996.
7.
SalminenJ.K., SaarijarviS., ArelaE., TalminenT.: Alexithymia–state or trait? One year follow-up study of general hospital psychiatric consultation out-patients. J Psychosom Res, 38: 681–685, 1994.
8.
SaarijarviS., SalminenJ.K., ToikkaT.B.: Temporal stability of alexithymia over a five-year period in outpatients with major depression. Psychoter Psychosom, 75: 107–112, 2006.
9.
HavilandM.G., ShawD.G., CummingsM.A., MacMurrayJ.P.: Alexithymia: subscales and relationship to depression. Psychother Psychosom, 50: 164–170, 1988.
10.
HonkalampiK., HintikkaJ., SaarinenP., LehtonenJ., ViinamakiH.: Is alexithymia a permanent feature in depressed patients? Results from a 6-month follow-up study. Psychother Psychosom, 69: 303–308, 2000.
11.
CorcosM., SperanzaM.: Psychopathologie de l'alexithymie.Dunod, Paris, 2003.
MarchesiC., BertoniS., CantoniA., MagginiC.: Is alexithymia a personality trait increasing the risk of depression? A prospective study evaluating alexithymia before, during and after a depressive episode. Psychol Med, 38: 1717–1722, 2008.
14.
FreybergerH.: Supportive psychotherapeutic techniques in primary and secondary alexithymia. Psychother Psychosom, 28: 337–342, 1977.
15.
LumleyM.A., StettnerL., WehmerF.: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res, 41: 505–518, 1996.
16.
KojimaM., Frasure-SmithN., LespéranceF.: Alexithymia following myocardial infarction: psychometric properties and correlates of the Toronto Alexithymia Scale. J Psychosom Res, 51: 487–495, 2001.
17.
WallerE., ScheidtC.E.: Somatoform disorders as disorders of affect regulation: a study comparing the TAS-20 with non-self-report measures of alexithymia. J Psychosom Res, 57: 239–247, 2004.
18.
Van De PutteE.M., EngelbertR.H., KuisW., KimpenJ.L., UiterwaalC.S.: Alexithymia in adolescents with chronic fatigue syndrome. J Psychosom Res, 63: 377–380, 2007.
19.
PorcelliP., TulipaniC., MaielloE., CilentiG., TodarelloO.: Alexithymia, coping and illness behaviour correlates of pain experience in cancer patients. Psychooncology, 16: 644–650, 2007.
20.
TodarelloO., La PesaM.W., ZakaS., MartinoV., LattanzioE.: Alexithymia and breast cancer. Psychother Psychosom, 51: 51–55, 1989.
21.
Pop-JordanovaN.: Alexithymia and cancer. Japanese Journal of Psychosomatic Medicine, 37: 585–588, 1997.
22.
MannaG., FoddaiE., Di MaggioM.G., PaceF., GebbiaN., RussoA.: Emotional expression and coping style in female breast cancer. Ann Oncol, 18(Suppl 6): 77–80, 2007.
23.
ServaesP., VingerhoetsAJJM, VreugdenhilG., KeuningJ.J., BroekhuijsenA.M.: Inhibition of emotional expression in breast cancer patients. Behav Med, 25: 23–27, 1999.
24.
Van DijkM., GrootenhuisM.A., De BoerM., BermondB., LastB.F.: Alexithymia in long-term survivors of childhood cancer. Pediatr Rehabil, 5: 203–237, 2002.
25.
GrassiL., RossiE., SabatoS., CrucianiG., ZambelliM.: Diagnostic criteria for psychosomatic research and psychosocial variables in breast cancer patients. Psychoter Psychosom, 73: 68–77, 2004.
26.
GrassiL., SabatoS., RossiE., BiancospinoB., MarmaiL.: Use of the diagnostic criteria for psychosomatic research. Psychoter Psychosom, 74: 100–107, 2005.
27.
MantaniT., SaekiT., InoueS., OkamuraH., DainoM., KataokaT., YamawakiS.: Factors related to anxiety and depression in women with breast cancer and their husbands: role of alexithymia and family functioning. Support Care Cancer, 15: 859–868, 2007.
28.
RipettiV., AusaniaF., BruniR., CampoliG., CoppolaR.: Quality of life following colorectal cancer surgery: the role of alexithymia. Eur Surg Res, 41: 324–330, 2008.
29.
StoneP., RichardsM., A'HernR., HardyJ.: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol, 11: 561–567, 2000.
30.
MaddenJ., NewtonS.: Why am I so tired all the time? Understanding cancer-related fatigue. Clin J Oncol Nurs, 10: 659–661, 2006.
31.
HardyJ., TurnerR., SaundersM., A'HernR.: Prediction of survival in a hospital-based continuing care unit. Eur J Cancer, 30A: 284–288, 1994.
32.
KingK.B., NailL.M., KreamerK, StrohlR.A., JohnsonJ.E.: Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum, 12: 55–61, 1985.
33.
ServaesP., VerhagenC., BleijenbergG.: Fatigue in cancer patients during and after treatment: prevalence, correlates, and interventions. Eur J Cancer, 38: 27–43, 2002.
SeoY.M., OhH.S., SeoW.S., KimH.S.: Comprehensive predictors of fatigue for cancer patients. Taehan Kanho Hakhoe Chi, 36: 1224–1231, 2006.
36.
ReuterK., ClassenC.C., RoscoeJ.A., MorrowG.R., KirshnerJ.J., RosenbluthR., FlynnP.J., ShedlockK., SpiegelD.: Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psychooncology, 15: 772–779, 2006.
37.
AhlbergK., EkmanT., WallgrenA., Gaston-JohanssonF.: Fatigue, psychological distress, coping and quality of life in patients with uterine cancer. J Adv Nurs, 45: 205–213, 2004.
38.
Pickard HolleyS.: Fatigue in cancer patients a descriptive study. Cancer Nurs, 14(1): 13–19, 1991.
39.
AkechiT., KugayaA., OkamuraH., YamawakiS., UchitomiY.: Fatigue and its associated factors in ambulatory cancer patients: A preliminary study. J Pain Symptom Manage, 17: 42–48, 1999.
40.
McArthurM.: Advanced clinical practice (cancer nursing): a study of fatigue in cancer patients receiving chemotherapy.University of Surrey, 1992.
41.
IrvineD., VincentL., GraydonJ.E., BubelaN., ThompsonL.: The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison with the fatigue experienced by healthy individuals. Cancer Nurs, 17: 367–378, 1994.
42.
SmetsE.M., VisserM.R., Willems-GrootA.F.: Fatigue and radiotherapy: (B) experience in patients nine months following treatment. Br J Cancer, 78: 907–912, 1998.
43.
SmetsE.M., VisserM.R., Willems-GrootA.F., GarssenB., OldenburgerF., van TienhovenG., de HaesJ.C.: Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer, 78: 899–906, 1998.
44.
AndyrowskyM.A., CurranS.L., LightenerR.: Off-treatment fatigue in breast cancer survivors: A controlled comparison. J Behaviour Med, 21: 1–18, 1998.
45.
SugawaraY., AkechiT., OkuyamaT., MatsuokaY., NakanoT., InagakiM., ImotoS., FujimoriM., HosakaT., UchitomiY.: Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer, 13: 628–636, 2005.
46.
MichielsenH.J., Van der SteegA.F., RoukemaJ.A., De VriesJ.: Personality and fatigue in patients with benign or malignant breast disease. Support Care Cancer, 15: 1067–1073, 2007.
47.
BagbyR.M., ParkerJ.D.A., TaylorG.J.: The Twenty-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res, 38: 23–32, 1994.
48.
ParkerJ.D.A., TaylorG.J., BagbyR.M.: The 20-item Toronto Alexithymia Scale. III. Reliability and factorial validity in a community population. J Psychosom Res, 55: 269–275, 2003.
49.
BressiC., TaylorG., ParkerJ., BressiS., BrambillaV., AgugliaE., AlegrantiI., BongiornoA., GibertiF., BuccaM., TodarelloO., CallegariC., VenderS., GalaC., InvernizziG.: Cross-validation of the factor structure of the 20-item Toronto Alexithymia Scale: An Italian multicenter study. J Psychosom Res, 41: 551–559, 1996.
50.
MendozaT.R., WangX.S., CleelandC.S., MorrisseyM., JohnsonB.A., WendtJ.K., HuberS.L.: The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer, 85: 1186–1196, 1999.
51.
MaggiE., CostantiniM., BellC., MarchettiM., BrogliaC., CatzedduT., BighinC., StevaniI., RossoR., VenturiniM., Del MastroL.: Psychometric properties of the Italian version of the Brief Fatigue Inventory. Ann Oncol, 13(Suppl 3): 61, 2002.
52.
MikolajczakM., LuminetO.: Is alexithymia affected by situational stress or is it a stable trait related to emotion regulation?Personality and Individual Differences, 40: 1339–1408, 2006.
53.
LuminetO., RokbaniL., OgezD., JadoulleV.: An evaluation of absolute and relative stability of alexithymia in women with breast cancer. J Psychosom Res, 62: 641–648, 2007.
De BerardisD., CampanellaD., GambiF., La RovereR., SepedeG., CoreL., CanforaG., SantilliE., ValcheraA., ManciniE., SalernoR.M., MoschettaF.S., FerroF.M.: Alexithymia, fear of bodily sensations, and somatosensory amplification in young outpatients with panic disorder. Psychosomatics, 48: 239–246, 2007.
56.
NakaoM., BarskyA.J.: Clinical application of somatosensory amplification in psychosomatic medicine. Biopsychosoc Med, 1: 17, 2007.
57.
AistarsJ.: Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum, 14: 25–30, 1987.
58.
GrabeH.J., SpitzerC., FreybergerH.J.: Alexithymia and personality in relation to dimension of psychopathology. Am J Psychiatry, 161: 1299–1301, 2004.
